Virtu Financial LLC Seagen Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$127.59 - $203.08 $290,139 - $461,803	2,274 New	2,274 $460,000
Q1 2022 May 17, 2022	SELL	$119.61 - $157.85 $744,093 - $981,984	-6,221 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$142.57 - $190.86 $886,927 - $1.19 Million	6,221 New	6,221 $962,000
Q2 2021 Sep 17, 2021	SELL	$135.08 - $161.1 $642,035 - $765,708	-4,753 Closed	0 $0
Q1 2021 May 19, 2021	SELL	$137.51 - $190.8 $324,386 - $450,097	-2,359 Reduced 33.17%	4,753 $660,000
Q4 2020 Feb 24, 2021	BUY	$164.63 - $211.93 $1.17 Million - $1.51 Million	7,112 New	7,112 $1.25 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.